Peripheral FAAH and soluble epoxide hydrolase inhibitors are synergistically antinociceptive

This publication has 57 references indexed in Scilit:

• Cytochrome P450 epoxygenase pathway of polyunsaturated fatty acid metabolism
  Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2015
• The role of long chain fatty acids and their epoxide metabolites in nociceptive signaling
  Prostaglandins & Other Lipid Mediators, 2014
• Peripheral gating of pain signals by endogenous lipid mediators
  Nature Neuroscience, 2014
• Stabilized epoxygenated fatty acids regulate inflammation, pain, angiogenesis and cancer
  Progress in Lipid Research, 2014
• Unique mechanistic insights into the beneficial effects of soluble epoxide hydrolase inhibitors in the prevention of cardiac fibrosis
  Proceedings of the National Academy of Sciences, 2013
• Development of an online SPE–LC–MS-based assay using endogenous substrate for investigation of soluble epoxide hydrolase (sEH) inhibitors
  Analytical and Bioanalytical Chemistry, 2011
• Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipids
  Journal of Lipid Research, 2010
• A Cytochrome P450-Derived Epoxygenated Metabolite of Anandamide Is a Potent Cannabinoid Receptor 2-Selective Agonist
  Molecular Pharmacology, 2009
• The Endocannabinoid Anandamide Is a Substrate for the Human Polymorphic Cytochrome P450 2D6
  The Journal of Pharmacology and Experimental Therapeutics, 2008
• Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies
  Analytical Biochemistry, 2005